Advanced search
Add to list

The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease

(2009) GASTROENTEROLOGY. 136(5, suppl. 1). p.A210-A210
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Arijs, I et al. “The Impact of Infliximab Therapy on Colonic Mucosal Expression of Barrier Genes in Patients with Inflammatory Bowel Disease.” Gastroenterology. Vol. 136. 2009. A210–A210. Print.
APA
Arijs, I., Quintens, R., Van Lommel, L., Van Steen, K., De Hertogh, G., Van Assche, G., Vermeire, S., et al. (2009). The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease. GASTROENTEROLOGY (Vol. 136, pp. A210–A210). Presented at the Digestive Disease Week ; 110th Annual meeting of the American Gastroenterological Association.
Chicago author-date
Arijs, I, R Quintens, L Van Lommel, Kristel Van Steen, G De Hertogh, GA Van Assche, S Vermeire, K Geboes, FC Schuit, and PJ Rutgeerts. 2009. “The Impact of Infliximab Therapy on Colonic Mucosal Expression of Barrier Genes in Patients with Inflammatory Bowel Disease.” In Gastroenterology, 136:A210–A210.
Chicago author-date (all authors)
Arijs, I, R Quintens, L Van Lommel, Kristel Van Steen, G De Hertogh, GA Van Assche, S Vermeire, K Geboes, FC Schuit, and PJ Rutgeerts. 2009. “The Impact of Infliximab Therapy on Colonic Mucosal Expression of Barrier Genes in Patients with Inflammatory Bowel Disease.” In Gastroenterology, 136:A210–A210.
Vancouver
1.
Arijs I, Quintens R, Van Lommel L, Van Steen K, De Hertogh G, Van Assche G, et al. The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease. GASTROENTEROLOGY. 2009. p. A210–A210.
IEEE
[1]
I. Arijs et al., “The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease,” in GASTROENTEROLOGY, Chicago, IL, USA, 2009, vol. 136, no. 5, suppl. 1, pp. A210–A210.
@inproceedings{5907126,
  author       = {Arijs, I and Quintens, R and Van Lommel, L and Van Steen, Kristel and De Hertogh, G and Van Assche, GA and Vermeire, S and Geboes, K and Schuit, FC and Rutgeerts, PJ},
  booktitle    = {GASTROENTEROLOGY},
  issn         = {0016-5085},
  language     = {eng},
  location     = {Chicago, IL, USA},
  number       = {5, suppl. 1},
  pages        = {A210--A210},
  title        = {The impact of infliximab therapy on colonic mucosal expression of barrier genes in patients with inflammatory bowel disease},
  volume       = {136},
  year         = {2009},
}

Web of Science
Times cited: